Novel Organic Cation Transporter 2-Mediated Carnitine Uptake in Placental Choriocarcinoma (BeWo) Cells

@article{Rytting2005NovelOC,
  title={Novel Organic Cation Transporter 2-Mediated Carnitine Uptake in Placental Choriocarcinoma (BeWo) Cells},
  author={Erik Rytting and Kenneth L. Audus},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2005},
  volume={312},
  pages={192 - 198}
}
  • E. Rytting, K. Audus
  • Published 1 January 2005
  • Biology
  • Journal of Pharmacology and Experimental Therapeutics
The placental transport of carnitine is significant because the fetus cannot supply itself with adequate amounts of this nutrient. Carnitine deficiencies in infants can lead to symptoms ranging from muscle weakness to sudden infant death. Objectives of this study include the characterization of novel organic cation transporter 2 (OCTN2) function in the BeWo cell line and the inhibition of placental carnitine uptake by amphetamine derivatives. BeWo cells were seeded in 12- or 24-well tissue… 

Figures and Tables from this paper

Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.

3H-DG apical uptake by BeWo cells is differentially modulated by different compounds present in drinks and by drugs of abuse.

Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells

Hypoxia resulted in significant reductions in OCTN2‐mediated carnitine uptake, and the OCTN1 substrate ergothioneine reversed the effects of hypoxia on Carnival transport, but identical concentrations of N‐acetylcysteine, another water‐soluble intracellular antioxidant, did not have the same effect.

The Carnitine Transporter Network: Interactions with Drugs

The current knowledge of the characterization of the carnitine transporter network and the interaction with drugs are reviewed with emphasis to the most recent data obtained using the proteoliposome reconstituted systems.

Caki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3

Confirmation for the usefulness of Caki-1 cells as a PT model system for investigations of OCT3 was obtained, a novel BLM localization of OCT2 was possible and relevant interactions between OCT3 and renally secreted drugs were shown.

Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomes

The data indicate that carnitine is a rate‐limiting factor for the maintenance of physiological butyrate oxidation in colonic cells, and this hypothesis could also explain the contradictory therapeutic efficacy ofbutyrate supplementation observed in clinical trials of IBD.

References

SHOWING 1-10 OF 30 REFERENCES

Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.

The results suggest that the carnitine deficiency-related toxicological effects by long-term treatment with such drugs might be ascribed to a functional alteration of hOCTN2-mediated carnitines transport.

Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.

L-Carnitine is essential for the translocation of acyl-carnitine into the mitochondria for beta-oxidation of long-chain fatty acids. It is taken up into the cells by the recently cloned Na(+)-driven

Up-Regulation of Carnitine Transporters Helps Maintain Tissue Carnitine Levels in Carnitine Deficiency Induced by Pivalic Acid

In the carnitine deficiency state induced by PVA, increased CLuptake owing to up-regulation of carn itine transporters is suggested to help maintain carnitines levels in some tissues.

Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2*

OCTN2 is a physiologically important, high affinity sodium-carnitine cotransporter in humans, and the functional characteristics of OCTN2 coincide with those reported for plasma membrane carnitine transport.

Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line.

Carnitine transport by organic cation transporters and systemic carnitine deficiency.

This minireview presents the recent knowledge about OCT and focus on carnitine transport, more particularly by the OCTN2, and describes the characteristics of the juvenile visceral steatosis mouse, an animal model of SCD showing similar symptoms as humans having this genetic disorder.

Valproic Acid Impairs Carnitine Uptake in Cultured Human Skin Fibroblasts. An In Vitro Model for the Pathogenesis of Valproic Acid–Associated Carnitine Deficiency

It is concluded that one mechanism by which long-term VPA therapy induces serum and tissue carnitine depletion is through inhibition of plasmalemmal carn itine uptake, including decreased renal reabsorption of free carnitines.

Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.

It is demonstrated in the present study that novel organic cation transporter (OCTN) 2 is a transporter for organic cations as well as carnitine and that OCTN2 is expressed not only in the heart, kidney, and placenta but also in the brain.

Mechanism and regulation of vitamin B(6) uptake by renal tubular epithelia: studies with cultured OK cells.

It is demonstrated that pyridoxine uptake by renal tubular epithelial OK cells is via a specialized pH-sensitive carrier-mediated mechanism, regulated by extracellular vitamin B(6) levels and an intracellular Ca(2+)/calmodulin-mediated pathway.